Hallmarks of neurodegenerative diseases

被引:583
|
作者
Wilson III, David M. [1 ]
Cookson, Mark R. [2 ]
Van Den Bosch, Ludo [3 ,4 ]
Zetterberg, Henrik [5 ,6 ,7 ,8 ,9 ,10 ]
Holtzman, David M. [11 ]
Dewachter, Ilse [1 ]
机构
[1] Hasselt Univ, Biomed Res Inst, BIOMED, B-3500 Hasselt, Belgium
[2] Natl Inst Aging, Lab Neurogenet, NIH, Bethesda, MD 20892 USA
[3] Univ Leuven, Expt Neurol & Leuven Brain Inst LBI, Dept Neurosci, KU Leuven, B-3000 Leuven, Belgium
[4] Ctr Brain & Dis Res VIB, Lab Neurobiol, B-3000 Leuven, Belgium
[5] Sahlgrenska Acad Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden
[6] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[7] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[8] UK Dementia Res Inst UCL, London, England
[9] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China
[10] UW, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[11] Washington Univ St Louis, Hope Ctr Neurol Disorders, Knight Alzheimers Dis Res Ctr, Dept Neurol, St Louis, MO USA
基金
美国国家卫生研究院; 欧洲研究理事会; 瑞典研究理事会; 欧盟地平线“2020”;
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; UBIQUITIN-PROTEASOME SYSTEM; MOTOR-NEURON DISEASE; ALPHA-SYNUCLEIN TOXICITY; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; DNA-DAMAGE; PARKINSON-DISEASE; OXIDATIVE STRESS; AMYLOID-BETA;
D O I
10.1016/j.cell.2022.12.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Decades of research have identified genetic factors and biochemical pathways involved in neurodegenera-tive diseases (NDDs). We present evidence for the following eight hallmarks of NDD: pathological protein ag-gregation, synaptic and neuronal network dysfunction, aberrant proteostasis, cytoskeletal abnormalities, altered energy homeostasis, DNA and RNA defects, inflammation, and neuronal cell death. We describe the hallmarks, their biomarkers, and their interactions as a framework to study NDDs using a holistic approach. The framework can serve as a basis for defining pathogenic mechanisms, categorizing different NDDs based on their primary hallmarks, stratifying patients within a specific NDD, and designing multi-tar-geted, personalized therapies to effectively halt NDDs.
引用
收藏
页码:693 / 714
页数:22
相关论文
共 50 条
  • [31] NEUROTOXINS AND NEURODEGENERATIVE DISEASES
    TIPTON, KF
    MCBEAN, GJ
    DAVEY, SP
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S65 - S65
  • [32] Glycosaminoglycans in Neurodegenerative Diseases
    Jin, Weihua
    Zhang, Fuming
    Linhardt, Robert J.
    ROLE OF GLYCOSYLATION IN HEALTH AND DISEASE, 2021, 1325 : 189 - 204
  • [33] Cannabinoids and Neurodegenerative Diseases
    Romero, Julian
    Martinez-Orgado, Jose
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 440 - 450
  • [34] Epilepsy in neurodegenerative diseases
    Neri, Sabrina
    Mastroianni, Giovanni
    Gardella, Elena
    Aguglia, Umberto
    Rubboli, Guido
    EPILEPTIC DISORDERS, 2022, 24 (02) : 249 - 273
  • [35] Polyphenols and neurodegenerative diseases
    Barreto, George E.
    Guedes, Rubem C. A.
    NUTRITIONAL NEUROSCIENCE, 2012, 15 (03) : 92 - 93
  • [36] Proteotoxicity and Neurodegenerative Diseases
    Ruz, Clara
    Luis Alcantud, Jose
    Vives Montero, Francisco
    Duran, Raquel
    Bandres-Ciga, Sara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 25
  • [37] Spermidine on neurodegenerative diseases
    Wang, I-Fang
    Tsai, Kuen-Jer
    Shen, Che-Kun James
    CELL CYCLE, 2015, 14 (05) : 697 - 698
  • [38] Metallothioneins and neurodegenerative diseases
    Hozumi, I
    Asanuma, M
    Yamada, M
    Uchida, Y
    JOURNAL OF HEALTH SCIENCE, 2004, 50 (04) : 323 - 331
  • [39] Hallucinations in Neurodegenerative Diseases
    Burghaus, Lothar
    Eggers, Carsten
    Timmermann, Lars
    Fink, Gereon R.
    Diederich, Nico J.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (02) : 149 - 159
  • [40] Peroxiredoxins in Neurodegenerative Diseases
    Szeliga, Monika
    ANTIOXIDANTS, 2020, 9 (12) : 1 - 19